Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gary Deutsch, MD
Northwell Health
Principal Investigator - Kenneth Gundle, MD
Oregon Health & Science University (OHSU)
Principal Investigator - Seth Pollack, MD
Fred Hutchinson Cancer Research Center/SCCA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Monter Cancer Center (northwell Health)
Lake Success, New York, United States
- Ohsu Knight Cancer Institute
Portland, Oregon, United States
- Fred Hutchinson Cancer Research Center/seattle Cancer Care Alliance (scca)/university of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2016
- Primary completion
- 22 Jul 2021
- Completion
- 22 Sept 2021
- Last update posted
- 24 Sept 2021
- Registered enrollment
- 23
- Registry id
- NCT03056599
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.